source
- Arvinas’ ‘Protac’ breast cancer drug cleared by FDAKnown as Veppanu, the drug is the first of its kind to get to market. But Arvinas and partner Pfizer are still searching for a new partner to sell it.BioPharma Dive · 4mo ago↗ source
- FDA approves Pfizer and Arvinas' breast cancer drug despite underwhelming dataThe FDA on Friday approved Pfizer and Arvinas' drug vepdegestrant for patients with a certain form of breast cancer. But it’s unclear how many will take it. The drug will be ...Endpoints · 4mo ago↗ source
- Pfizer earns positive Phase 3 in multiple myeloma; ICON overstated revenuePfizer’s positive Phase 3 data in multiple myeloma: The company’s Elrexfio produced a “statistically significant and clinically meaningful improvement” in progression-free survival in patients with…